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MicroRNA-203 Regulates Melanosome Transport and
Tyrosinase Expression in Melanoma Cells by Targeting
Kinesin Superfamily Protein 5b
Shunsuke Noguchi1, Minami Kumazaki1,2, Yuki Yasui1,2, Takashi Mori3, Nami Yamada4 and Yukihiro Akao1
MicroRNA (miR)-203 is known to be downregulated and to act as an anti-oncomir in melanoma cells. At present,
we found that exogenous miR-203 increased pigmentation and protein expression levels of the melanoma
antigen recognized by T cells (Melan-As/MART1s) and/or tyrosinase (TYR) in the human melanoma cells tested.
Inversely, treatment with an inhibitor of miR-203 downregulated the expression level of TYR. The target gene of
miR-203 involved in the mechanism was kinesin superfamily protein 5b (kif5b), which was revealed by gene
silencing using short interfering RNA and luciferase activity assay. Furthermore, immunocytochemistry showed
obvious accumulation of melanosomes around nuclei of human melanoma Mewo cells transfected with miR-203
or siR-kif5b. Importantly, treatment with the miR-203 inhibitor, but not miR-203, exhibited effects on human
epidermal melanocytes isolated from lightly pigmented adult skin similar to those on melanoma cells. In
addition, the data indicated that exogenous miR-203 also negatively regulated the cAMP response element–
binding protein 1 (CREB1)/microphthalmia-associated transcription factor (MITF)/Rab27a pathway, which is one of
the main pathways active in melanoma cells. In conclusion, our data indicated that anti-oncogenic miR-203 had a
pivotal role in melanoma through reducing melanosome transport and promoting melanogenesis by targeting
kif5b and through negative regulation of the CREB1/MITF/Rab27a pathway.
Journal of Investigative Dermatology (2014) 134, 461–469; doi:10.1038/jid.2013.310; published online 15 August 2013
INTRODUCTION
Mammalian epidermal melanocytes and melanoma cells, the
latter originating from melanocytes, are specialized for the
production of melanin pigment. Skin pigmentation results
from a complex multistep process culminating in the distribu-
tion of melanin pigments throughout the various layers of
the epidermis. The human body is protected from UVR by
these pigments, and their excess production often induces
hyperpigmentation. Melanosomes synthesize and preserve
melanin pigments in melanocytes (Raposo and Marks,
2007). The melanosomes are mainly produced around the
nucleus. Then, mature melanosomes are transported along
microtubules and actin filaments, and finally arrive at the
plasma membrane (Raposo and Marks, 2007). Kinesin
superfamily proteins (KIFs) function as motors that move
along microtubules and serve to carry cargoes such as
membranous organelles, protein complexes, and mRNAs
(Hirokawa et al., 2009). For example, KIF5b contributes to
the outward transport of melanosomes (Hara et al., 2000).
However, the precise mechanism underlying KIF-mediated
melanosome transport via microtubules remains unclear. On
the other hand, the key regulators of actin-based melanosome
transport are myosin Va (Myo 5a), Rab27a, and Slac2-a
(Ohbayashi and Fukuda, 2012).
Several important proteins contributing to melanogenesis
have been clarified. Tyrosinase (TYR) is the most important
enzyme of melanin synthesis, and its expression is induced by
exposure to UVR as part of the pigmentation process. TYR acts
with TYR-related protein 1 and dopachrome tautomerase to
synthesize melanin (Costin et al., 2005). The TYR gene family
members such as TYR and TYR-related protein 1 contribute to
the initiation of pigment synthesis in stage-3 melanosomes
(Raposo and Marks, 2007). Another important factor
involved in melanin synthesis is microphthalmia-associated
transcription factor (MITF), which not only regulates the
survival and proliferation of melanocytes but also promotes
the transcription of several pigmentation genes (e.g., TYR and
TYRP1) (Vachtenheim and Borovansky, 2010; Levy and Fisher,
2011). MITF also regulates, in a positive manner, the
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expression of Rab27a, which is a regulator of actin-based
melanosome transport (Chiaverini et al., 2008). On the other
hand, melanoma antigen recognized by T cells (Melan-
As/MART-1s) is a melanoma-specific antigen and also
participates in melanosome biogenesis. In particular, it has
been suggested that Melan-A has a role in early melano-
genesis, because Melan-A is abundantly expressed in early
melanosomes (De Maziere et al., 2002; Basrur et al., 2003).
MicroRNAs (miRNAs or miRs) have recently been identi-
fied as short (18–25 nucleotides), noncoding, small RNA
molecules that suppress gene expression by binding to the
complementary region of the 30-untranslated region of their
target mRNA (Cannell et al., 2008; Sun et al., 2008; Bartel,
2009). Over 1,300 miRNAs have been predicted to exist
in humans (miRBase; http://www.mirbase.org/, accessed
1 December 2012). Furthermore, a recent report estimates
that the number of recognized conserved miRNAs will
increase with further study (Chiang et al., 2010). Much
experimental evidence has confirmed the role of miRNAs
in the regulatory network of various physiological or
pathophysiological processes such as development (Harfe,
2005), differentiation (Zhang et al., 2009), cellular apoptosis
(Lynam-Lennon et al., 2009), cell proliferation (Kaddar et al.,
2009), and the development and progression of cancer
(Cho, 2010, 2012; van Kempen et al., 2012). Recently,
Dynoodt et al. (2013) reported that miR-145 regulates
melanosome transport and melanogenesis by targeting myo
5a. However, miRNA-associated mechanisms of melanosome
transport and melanogenesis have mostly remained unknown.
We recently reported that miR-203 is downregulated and
functions as an anti-oncomir in canine and human melanoma
cells (Noguchi et al., 2012, 2013b). In addition, miR-203
functions as a tumor suppressor in various kinds of cancer
such as breast cancer, lung cancer, and squamous cell
carcinoma (Takeshita et al., 2012; Wang et al., 2012; Jin
et al., 2013). Thus, its anti-oncogenic function has been
a matter of focus. In this present study, we identified
miR-203 as a regulator of melanosome transport and melano-
genesis in melanoma cells. Furthermore, we comprehensively
validated the mechanisms of melanosome transport and
melanogenesis, which mechanisms involved a target gene of
miR-203, i.e., KIF5b.
RESULTS
Exogenous miR-203 suppressed the growth of melanoma cells
and regulated the pigmentation process
Exogenous miR-203 suppressed the growth of melanoma
Mewo and A2058 cells (Figure 1a), in which miR-203 is
downregulated compared with that in human normal epider-
mal melanocytes (Noguchi et al., 2013b). Consistently, we
found that transfection of Mewo cells with miR-203 resulted in
hyperpimentation, as shown by Masson–Fontana ammoniacal
silver staining (Figure 1b). Furthermore, western blotting
analysis revealed that exogenous miR-203 increased the
expression levels of Melan-A, HMB45, and TYR in Mewo
cells (Figure 1c). Exogenous miR-203 also upregulated the
TYR expression level in the amelanotic cell line A2058, in
which no expression of Melan-A and HMB45 was observed
(Figure 1c). These results led us to hypothesize that miR-203
contributed to melanogenesis and/or melanosome transport.
Therefore, we focused on two KIFs, i.e., kif2a and kif5b, and
myo 5a as potential target genes of miR-203 (http://www.tar-
getscan.org/, accessed 5 August 2012). The transfection with
miR-203 reduced the protein expression levels of KIF5b and
KIF2a in both Mewo and A2058 cells (Figure 1c), as well as
the mRNA expression levels of them in Mewo cells
(Figure 1d). On the other hand, the expression level of Myo
5a in the Mewo cells was almost unchanged compared with
that in the control (Figure 1c).
Transfection with an inhibitor of miR-203 showed effects
opposite to those observed with exogenous miR-203
Transfection with an miR-203 inhibitor significantly enhanced
the growth of Mewo and A2058 cells (Figure 2a). Furthermore,
the expression levels of KIF2a and KIF5b were upregulated by
this transfection (Figure 2b). On the contrary, the expression
level of TYR was downregulated by it. Unexpectedly, in
Mewo cells, the expression level of Melan-A was almost
unchanged and that of HMB45 was markedly increased, even
at 10 nM (Figure 2b). Hyperpigmentation was not grossly
observed (data not shown).
miR-203 directly targeted kif2a and kif5b, but not myo 5a
Next, we performed luciferase activity assays for kif2a, kif5b,
and myo 5a to validate whether miR-203 targeted these genes.
As shown in Figure 2c, miR-203 did not affect the luciferase
activity of pMIR-myo 5a-wild or -mutant. On the other hand,
it did significantly suppress luciferase activities of pMIR-kif2a-
wild and pMIR-kif5b-wild. In addition, mutation of the kif5b
30-untranslated region-binding site (pMIR-kif5b-mut) markedly
abolished the ability of miR-203 to regulate luciferase expres-
sion, and that of the kif2a one did so to a lesser degree. These
results clearly demonstrate that miR-203 directly targeted kif2a
and kif5b, but not myo 5a.
KIF5b regulated TYR expression level
Next, we examined the effect of silencing kif2a or kif5b by
using short interfering RNA (siRNA) to validate the role of
these genes in melanogenesis. The silencing of kif2a did not
affect the cell growth of the melanoma cells tested (Figure 3a).
On the other hand, kif5b silencing moderately, but signifi-
cantly, suppressed that of Mewo cells at a concentration of
0.5 nM. Importantly, the knockdown of kif5b increased the
TYR expression level in both Mewo and A2058 cells
(Figure 3b). Knockdown of kif5b also increased the expression
levels of Melan-A and HMB45 in Mewo cells, but not in
A2058 cells, which did not express Melan-A and HMB45.
kif2a silencing did not upregulate the expression levels of
Melan-A and/or TYR in the cells tested (Figure 3b). However,
unexpectedly, the HMB45 expression level in the Mewo cells
was increased by kif2a silencing.
We also examined the expression levels of Akt and ERK1/2
as representative cell growth signaling pathways, because
kif5b silencing showed a moderately suppressive effect on
the growth of the Mewo cells. As a result, silencing of kif2a
or kif5b upregulated the level of p-Akt and slightly
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downregulated that of p-ERK1/2 in Mewo cells, whereas the
levels of Akt and ERK1/2 in these cells were almost unchanged
(Figure 3b).
KIF5b regulated the intracellular distribution of melanosomes,
and the distribution of KIF5b was consistent with that of the
melanosomes
Immunofluorescence analysis showed that melanosome mar-
ker HMB45 obviously accumulated around the nuclei of
Mewo cells transfected with miR-203 or siR-kif5b, indicating
blockage of melanosome transport, whereas HMB45 was
distributed diffusely in dendrites and around the nuclei in
the cells transfected with control miRNA or siR-kif2a
(Figure 4a and b). Furthermore, the intracellular distribution
of HMB45 was consistent with that of KIF5b, but not with that
of KIF2a (Figure 4b and c). Strong expression of KIF2a was
observed in the nuclei (Figure 4b). These findings indicated
that miR-203 reduced melanosome transport by negatively
regulating the expression level of KIF5b.
miR-203 inhibitor enhanced the growth of HEMa-LP cells and
contributed to diffuse distribution of melanosomes
The expression level of miR-203 in human normal epidermal
melanocytes, human epidermal melanocytes isolated from
lightly pigmented adult skin (HEMa-LP), was significantly
upregulated compared with that in Mewo cells, but not
compared with that in A2058 cells (Figure 5a). The expression
level of KIF5b in HEMa-LP and melanoma cells appeared to
be inversely correlated with that of miR-203 (Figure 5a and b).
Consistent with the case for melanoma cells, the transfection
with the miR-203 inhibitor enhanced the growth of HEMa-LP
(Figure 5c), upregulating KIF5b expression and downregulat-
ing TYR expression (Figure 5d), although exogenous miR-203
had no effect.
We also examined the intracellular distribution of melano-
somes in HEMa-LP using immunofluorescence analysis. As
shown in Figure 5e, melanosomes tended to have accumu-
lated around the nuclei in the cells treated with control
miRNA or miR-203, whereas they were diffusely localized
in the cells treated with the miR-203 inhibitor. However, the
alteration of melanosome distribution was smaller than that in
Mewo cells.
miR-203 regulated the expression levels of cAMP response
element–binding protein 1, MITF, and Rab27a in Mewo cells
Our data indicated that exogenous miR-203 positively regu-
lated the expression level of TYR. Thus, we also performed
western blotting to examine the expression levels of p-cAMP
response element–binding protein 1 (CREB1) and CREB1,
the former of which is a transcription factor of the mitf gene.
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Figure 1. Exogenous microRNA (miR-203) suppressed the cell growth, induced hyperpigmentation, and downregulated the expression levels of kinesin
superfamily proteins (KIFs). (a) Exogenous miR-203 suppressed the growth of melanoma cells. (b) Mewo cells stained with Masson–Fontana ammoniacal silver
stain. Bar¼20mm. (c) Expression levels of various proteins by western blotting. N.E, not expressed. (d) mRNA expression levels of kif2a and kif5b in Mewo cells
were downregulated by exogenous miR-203. The cell count, protein extraction, and RNA extraction were performed at 96 (Mewo) or 72 (A2058) hours after the
transfection. *Po0.01. A P-value was determined for the difference between the cells transfected with control miRNA and those transfected with miR-203. Data
are expressed as the meanþ SD (n¼ 3). Cont, control.
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Its product, MITF, is one of the key regulators of melanogen-
esis and survival and proliferation of melanocytes. We also
examined the expression of Rab27a, which is a downstream
molecule of MITF and one of the key regulators of actin-
based melanosome transport. Exogenous miR-203 downregu-
lated the expression levels of CREB1, MITF, and Rab27a,
although the level of p-CREB1 remained almost unchanged
(Figure 6a). Inversely, the treatment with the miR-203 inhibitor
increased the protein expression levels of these genes.
On the other hand, the expression level of MITF was
unchanged, and that of Rab27a was increased, by silencing
of kif2a or kif5b.
DISCUSSION
We recently reported that exogenous miR-203 induces cellular
senescence by targeting E2F3 in melanoma cells (Noguchi
et al., 2012). In the current study, we found that treatment
of Mewo cells with exogenous miR-203 resulted in
hyperpigmentation of the cells. We unraveled part of the
mechanisms of the pigmentation process and melanosome
transport by transfecting melanoma cells with miR-203. As
the results obviously showed, miR-203 contributed to
melanogenesis by increasing the number of melanosomes
through negative regulation of KIF5b expression. Our data
also revealed that the mechanism for upregulation of TYR by
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Figure 4. Exogenous microRNA (miR)-203 or kif5b silencing inhibited melanosome transport in Mewo cells. Immunostaining by the immunofluorescence
method was performed 96 hours after transfection with control miRNA, miR-203, miR-203 inhibitor, or each short interfering RNA (siRNA). (a) HMB45
accumulated around the nuclei in the cells transfected with miR-203 or siR-kif5b. On the other hand, HMB45 was also observed in the peripheral region of the
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(c) The intracellular distribution of KIF5b and HMB45 was coincidental. Nuclei were counterstained in blue with Hoechst33342. Bar¼ 20mm. Cont, control.
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miR-203 was independent of MITF, because exogenous miR-
203 downregulated the expression level of MITF. Furthermore,
the downregulation of KIF5b by miR-203 resulted in the
inhibition of melanosome transport. KIF5b belongs to the
N-kinesin family and transports mature melanosomes toward
the peripheral region along microtubules (Ohbayashi and
Fukuda, 2012; Ohbayashi et al., 2012). However, it has never
been reported that KIFs regulate TYR expression. Therefore, a
further detailed study is needed to reveal the mechanism by
which KIF5b regulates TYR.
On the other hand, as was shown in Figures 2a and 3b, the
transfection with the miR-203 inhibitor or siR-kif2a also
increased the expression level of HMB45 without upregulating
that of TYR. Therefore, we examined the time-dependent
changes in the expression levels of various proteins in Mewo
cells transfected with miR-203 or miR-203 inhibitor. The
results shown in Supplementary Figure S1a and b online
revealed that the expression levels of HMB45, Melan-A, and
TYR in Mewo cells were transiently decreased after the
transfection with control miRNA. Then, they were increased,
consistent with the accelerating cell growth. The HMB45
expression level in the cells transfected with each miRNA was
increased to almost the same level found at 0 hour after the
transient decrease. On the other hand, the expression levels
of Melan-A and TYR in the cells transfected with miR-203
were increased to more than twice the level at 0 hour after
the transient reduction in spite of the arrested cell growth.
The transient decrease in protein expression levels was
not associated with the expression level of miR-203
(Supplementary Figure S1c online). These results indicate that
upregulation of HMB45 was a nonspecific effect and not
directly related to melanogenesis.
We also validated the effects of exogenous miR-203 or the
inhibition of endogenous miR-203 expression on HEMa-LP
cells (Figure 5). At first, we examined the expression level of
miR-203 in HEMa-LP and the melanoma cells tested. As a
result, unexpectedly, the expression level of miR-203 in
HEMa-LP cells, procured from Invitrogen (Carlsbad, CA),
was markedly lower than that in A2058 cells, inconsistent
with the results obtained with human normal epidermal
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melanocytes, HEMs, from ScienCell Research Laboratories
(Carlsbad, CA) in our previous study (Noguchi et al.,
2013b). These results indicate that the characteristics of
melanocytes, such as the amount of pigment and the
passage number, affect the expression level of miR-203.
Importantly, however, exogenous miR-203 did not affect the
growth or biochemical phenotype of the HEMa-LP cells. These
data indicate that the effects of exogenous miR-203 on normal
melanocytes were smaller than those on melanoma cells.
In addition, we examined the effects of intratumoral injec-
tion of miR-203 into mice bearing xenografted Mewo cells.
We determined that the injection dose of miR-203 was
0.3 nmol per administration, which was determined by the
results found in our previous study (Noguchi et al., 2013a). As
shown in Supplementary Figure S2 online, the effects of miR-
203 administration in vivo on the expression levels of TYR and
KIF5b were mostly consistent with those obtained in vitro.
However, no obvious tumor-suppressive effects were observed
(data not shown), possibly caused by no significant repression
of the expression levels of p-CREB and CREB (Supplementary
Figure S2 online). Accordingly, to assess the tumor-suppressive
effect of miR-203 in vivo, a higher dose of miRNA and
extended experimental period might be explored in the future.
We validated the expression level of MITF in Mewo cells,
because the TYR expression level was increased by transfec-
tion with miR-203 or siR-kif5b. Interestingly, the results
showed that the MITF expression level was decreased by
exogenous miR-203, whereas kif5b silencing did not affect it.
These results suggest that the mechanism regulating TYR
involved not only MITF but also KIF5b. We hypothesized that
miR-203 targeted an upstream molecule of mitf. Based on the
database (http://www.targetscan.org/, accessed 1 February
2013), we focused on creb1 as a potential target gene of
miR-203. CREB is activated by phophorylation at its Ser133,
and the activated CREB increases mitf gene expression (Wan
et al., 2011). Our data indicated that miR-203 regulated MITF
expression level by targeting creb1. Subsequently, Rab27a
expression was suppressed through downregulation of MITF,
because MITF regulates Rab27a and TYR (Chiaverini et al.,
2008). Thus, a further study should focus on the function
of the miR-203/CREB1/MITF/Rab27a pathway in melanoma
development and progression to elucidate the comprehensive
role of miR-203 in melanoma.
In addition, we attempted to reveal the significance of KIF2a
suppression by exogenous miR-203. KIF2a regulates neural
migration by the uncontrolled elongation of axon collaterals
(Homma et al., 2003). Therefore, we performed an invasion
assay by using matrigel invasion chambers (Becton and
Dickinson, Franklin Lakes, NJ). The results shown in
Supplementary Figure S3 online indicated that exogenous
miR-203 significantly inhibited the migration of both mela-
noma cell lines tested and that this inhibition was partly
associated with the suppression of KIF2a in Mewo cells.
However, further comprehensive studies are needed to dis-
close the function of KIF2a in melanoma cells.
In conclusion, we showed that miR-203 directly regulated
microtubule-based melanosome transport in a negative man-
ner by targeting kif5b in melanoma cells. In addition, our data
indicated that miR-203 regulated TYR expression without
upregulating MITF expression and possibly regulated actin-
based melanosome transport by suppressing Rab27a, a down-
stream molecule of CREB1. Altogether, our data indicate
that miR-203 had a pivotal role in melanoma cells, reducing
melanosome transport and promoting the pigmentation
process (Figure 6b).
MATERIALS AND METHODS
Cell culture and cell viability
Human malignant melanoma cell lines A2058 and Mewo were
purchased from Health Science Research Resources Bank (Osaka,
Japan). HEMa-LPs were obtained from Invitrogen. The cells were
maintained according to the manufacturer’s protocol. The number of
viable cells was determined by performing the trepan blue dye
exclusion test.
Cell transfection with miRNA or siRNA
The cells were seeded into six-well plates at a concentration of
0.5 105 (Mewo and A2058) or 1.0 105 (HEMa-LP) cells per well
the day before transfection. We used Pre-miR-203 (Applied Bios
stems, Foster City, CA) as an miR-203 mimic and nirvana miRNA
inhibitor for hsa-miR-203 as an miR-203 inhibitor (Applied Bios
stems) for transfection into cells. Transfection was achieved by
using cationic liposome’s, Lipofectamine RNAiMAX (Invitrogen),
at a concentration of 5–20 nM (miR-203) or 10–40 nM (miR-203
inhibitor), according to the manufacturer’s Lipofection protocol.
siRNAs for kif2a and kif5b were also used for transfection of the
cells, 50-UAAUCUGAAACACUGCAUGGCUCCG-30 (siR-kif2a) and
50-CAGAUCUCCGCUGUGAACUUCCUAA-30 (siR-kif5b; Invitro-
gen). Pre-miR miRNA Precursor Molecules-Negative Control no. 2
(Applied Biosystems) was used as a nonspecific control miRNA.
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Figure 6. Exogenous microRNA (miR-203) downregulated the expression
levels of CREB, MITF, and Rab27a in Mewo cells. (a) Exogenous miR-203
downregulated the expression levels of CREB, MITF, and Rab27a, whereas the
MITF expression level remained almost unchanged. The Rab27a expression
level was upregulated in the cells transfected with siR-kif2a or kif5b. Each short
interfering RNA was used at a concentration of 0.1 nM. The protein extraction
was performed at 96 hours after the transfection. (b) Flow diagram of the target
genes of miR-203 and the related pathways of melanosome transport and
melanogenesis. Cont, control.
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Western blotting
Total protein was extracted from whole cells by the procedure
described previously (Noguchi et al., 2011). Protein contents were
measured with a DC Protein Assay Kit (Bio-Rad, Hercules, CA). Ten
micrograms of lysate protein for western blotting was separated by
SDS-PAGE using polyacrylamide gels and electroblotted onto a
polyvinylidene difluoride membrane (PerkinElmer Life Sciences,
Boston, MA). Details of the method used after blotting were
described earlier (Noguchi et al., 2011). The antibodies used in this
study were anti-human KIF2a rabbit polyclonal antibody (Bethyl
Laboratories, Montgomery, TX), anti-human KIF5b rabbit polyclonal
antibody, anti-human TYR mouse mAb, anti-human HMB45 mouse
mAb, anti-human MITF rabbit polyclonal antibody, anti-human
Rab27a mouse mAb (Santa Cruz Biotechnology, Santa Cruz, CA),
anti-human Akt rabbit polyclonal antibody, anti-human
phosphorylated-Akt (Ser473; p-Akt) rabbit polyclonal antibody, anti-
human ERK1/2 rabbit mAb, anti-human phosphorylated-ERK1/2
(Thr202/Tyr204; p-ERK1/2) rabbit mAb, anti-human Myo 5a rabbit
polyclonal antibody, anti-human CREB rabbit mAb, and anti-human
phosphorylated-CREB (Ser133; p-CREB) rabbit mAb (Cell Signaling
Technology, Danvers, MA), all of which were properly diluted
with Tris-buffered saline and Tween 20 containing 2% BSA and
0.01% sodium azide. The loading control was prepared by
re-incubating the same membrane with anti-human b-actin
antibody (Sigma, St Louis, MO).
Masson–Fontana ammoniacal silver staining
For the detection of melanin pigment, Mewo cells were plated on
13-mm glass coverslips (Matsunami Glass Industry, Osaka, Japan) in
1.0 ml of culture medium plus 10% (w/v) fetal bovine serum per well
of a six-well plate. At 96 hours after the transfection, cells were fixed
with 100% methanol. Then, they were stained according to the
Masson–Fontana ammoniacal silver staining method. Briefly, cells
were incubated in ammoniacal silver solution overnight. After fixation
in acid-fixing solution, they were stained with kernechtrot.
Quantitative reverse transcriptase PCR using real-time PCR
Total RNA was isolated from cells by the phenol/guanidium thiocya-
nate method with DNase I treatment. For determination of mRNA
expression levels, total RNA was reverse transcribed with a Prime-
Script RT Reagent Kit (TaKaRa, Otsu, Japan). Real-time PCR was then
performed using SYBR Premix Ex Taq (TaKaRa). The relative expres-
sion level of mRNA was calculated by the DDCt method. Glycer-
aldehyde-3-phosphate dehydrogenase was used as an internal
control.
To determine the expression of miRNAs, we used TaqMan
MicroRNA Assays (hsa-miR-203 and RNU6B; Applied Biosystems)
to reverse transcribe the mature miRNA sequences to their cDNA.
The PCR procedure was performed using real-time PCR according to
our previous study (Noguchi et al., 2013b). The relative expression
level of miR-203 was calculated by the DDCt method. RNU6B was
used as an internal control.
Assay for luciferase activity
We constructed the sensor vector by joining the regions with
a possible binding site from the 30-untranslated region of human
kif2a, kif5b, or myo 5a to a luciferase reporter pMIR-control vector
(Applied Biosystems) to examine the target sequence recognized by
miR-203. For amplification of those mRNAs, total RNA was reverse
transcribed with a PrimeScript RT Reagent Kit (TaKaRa).
The sequences of the primers used in this study were as follows:
kif2a-sense-2361, 50-TTCCGTGCACGTCTACAAGA-30; kif2a-
antisense-2728, 50-CTGGCTCTGGATTGAGTCCA-30; kif5b-sense-
5283, 50-CATGGGTATTGGTGCTGTGT-30; kif5b-antisense-5711,
50-CTCTTCTGTCACCTCATGTC-30; myo 5a-sense-11424, 50-CAG
TGCTTGGCAGGTTAGTA-30; and myo 5a-antisense-11681, 50-TTTG
CGCAACACTGTTAGCG-30. In addition, to generate the sensor
vectors with 2 or 3 mutations in the binding site for miR-203, we
mutated seed regions from CATTTCA to CAACGCA (mut; PrimeSTAR
Mutagenesis Basal Kit; TaKaRa). The sensor vectors with mutations
were submitted to Life Science Research Center, Gifu University, for
DNA sequencing. Mewo cells were seeded in 12-well plates at a
concentration of 0.5 105 per well the day before the transfection.
The sensor vector (concentration, 0.5mg per well) and 20 nM miR-
203 or nonspecific control miRNA were used for the co-transfection
of the cells by using cationic liposomes Lipofectamine RNAiMAX.
Forty-eight hours after the co-transfection, luciferase activities were
measured by using a Dual-Glo Luciferase Assay System (Promega,
Madison, WI) according to the manufacturer’s protocol. Firefly
luciferase activity was normalized to Renilla luciferase activity.
Immunocytochemistry
Mewo cells were plated on 13-mm glass coverslips (Matsunami Glass
Industry) in 1.0 ml of culture medium plus 10% (w/v) fetal
bovine serum per well of a six-well plate, and HEMa-LP was
added onto two-well chamber slides (Thermo Fisher Scientific,
Rochester, NY). At 96 hours after the transfection, cells were
immunostained with anti-HMB, anti-KIF2a, or anti-KIF5b antibody
according to the immunofluorescence protocol of Cell Signaling
Technology. The nuclei were stained with Hoechst33342, and for
actin labeling the cells were incubated with the fluorescent F-actin
probe Rhodamine Phalloidin (Cytoskeleton, Denver, CO). The cells
were viewed with a BIOREVO fluorescence microscope (Keyence,
Osaka, Japan).
Statistics
Each examination was performed in triplicate. All calculated data
were compared by using Student’s t-test. A P-value o0.05 was
considered to be statistically significant.
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